Scholarlink

Background <p>Despite policy efforts to promote Jan Aushadhi medicines (JAM) in India, their utilization for chronic disease management remains limited, particularly among patients with Type 2 Diabetes Mellitus (T2DM). Understanding stakeholder perceptions is critical to improving acceptance and uptake.</p> Methods <p>A qualitative descriptive study was conducted in Mysuru Taluka, Karnataka. A total of 29 participants, including T2DM patients, public and private healthcare providers, pharmacists, and Auxiliary Nurse Midwives, were recruited using purposive sampling. Data were collected through in-depth interviews and a focus group discussion and analyzed using inductive thematic analysis supported by NVivo software.</p> Results <p>Private healthcare providers and branded-medicine users expressed skepticism regarding JAM quality and efficacy, while public providers and ASHAs emphasized affordability but reported mistrust and inconsistent availability. Limited provider endorsement emerged as a key barrier influencing patient medicine choices.</p> Conclusion <p>The study highlights that perceptions of quality, provider influence, and system-level constraints shape JAM utilization among T2DM patients. Addressing these barriers through targeted provider engagement and patient-focused communication strategies may enhance acceptance of JAM.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Patient perceptions and barriers influencing the utilization of generic medicines among individuals with Type 2 Diabetes Mellitus in Mysuru India: a qualitative study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月19日

查看全文
  • B. C. Sulochanadevi,
  • H. K. Mamatha,
  • N. Devadasan,
  • G. R. Yashaswini,
  • D. M. Shilpa,
  • M. C. Manjunatha,
  • B. Madhu

摘要

Background

Despite policy efforts to promote Jan Aushadhi medicines (JAM) in India, their utilization for chronic disease management remains limited, particularly among patients with Type 2 Diabetes Mellitus (T2DM). Understanding stakeholder perceptions is critical to improving acceptance and uptake.

Methods

A qualitative descriptive study was conducted in Mysuru Taluka, Karnataka. A total of 29 participants, including T2DM patients, public and private healthcare providers, pharmacists, and Auxiliary Nurse Midwives, were recruited using purposive sampling. Data were collected through in-depth interviews and a focus group discussion and analyzed using inductive thematic analysis supported by NVivo software.

Results

Private healthcare providers and branded-medicine users expressed skepticism regarding JAM quality and efficacy, while public providers and ASHAs emphasized affordability but reported mistrust and inconsistent availability. Limited provider endorsement emerged as a key barrier influencing patient medicine choices.

Conclusion

The study highlights that perceptions of quality, provider influence, and system-level constraints shape JAM utilization among T2DM patients. Addressing these barriers through targeted provider engagement and patient-focused communication strategies may enhance acceptance of JAM.